Discontinuation of Dapoxetine Treatment in Patients With Premature Ejaculation: A 2-Year Prospective Observational Study

Discontinuation of Dapoxetine Treatment in Patients With Premature Ejaculation: A 2-Year Prospective Observational Study

Introduction: Although dapoxetine is the only oral pharmacologic agent approved for the treatment of premature ejaculation (PE) and is very effective, the discontinuation rate is high. Aim: To assess the discontinuation rate of patients with PE and the reasons for discontinuation in real-world pract...

Full description

Bibliographic Details
Main Authors: Hyun Jun Park, MD, PhD, Nam Cheol Park, MD, PhD, Tae Nam Kim, MD, Seung Ryong Baek, MD, Kyung Min Lee, MS, Sangmin Choe, MD, PhD
Format: Article
Language:English
Published: Elsevier 2017-06-01
Series:Sexual Medicine
Subjects:
Premature Ejaculation
Serotonin Uptake Inhibitors
Compliance
Online Access:http://www.sciencedirect.com/science/article/pii/S2050116117300193

Internet

http://www.sciencedirect.com/science/article/pii/S2050116117300193

Similar Items